Modification of lipoprotein metabolism and function driving atherogenesis in diabetes

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · see citing works

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536 · see citing works

Pathophysiology of type 2 diabetes mellitus

Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360 · see citing works

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works

Vascular smooth muscle cells in atherosclerosis

Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179 · see citing works

Inflammation in obesity, diabetes, and related disorders

Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066 · see citing works

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

SCORE2 working group and ESC Cardiovascular risk collaboration, Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab309 · Cited by 1,810 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

The Response-to-Retention Hypothesis of Early Atherogenesis

Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413 · see citing works

CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,247 · see citing works

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019 · see citing works

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Kwiterovich, P. O., Blumenthal, R. S., & Jones, S. R. (2013) · JAMA · doi:10.1001/jama.2013.280532 · Cited by 883 · see citing works

Global epidemiology of dyslipidaemias

Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00541-4 · Cited by 882 · see citing works

Decreased IRS-2 and Increased SREBP-1c Lead to Mixed Insulin Resistance and Sensitivity in Livers of Lipodystrophic and ob/ob Mice

Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 847 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771 · see citing works

LOX-1, OxLDL, and Atherosclerosis

Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 768 · see citing works

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Das Pradhan, A., Glynn, R. J., Fruchart, J.-C., MacFadyen, J. G., Zaharris, E. S., Everett, B. M., Campbell, S. E., Oshima, R., Amarenco, P., Blom, D. J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2210645 · Cited by 749 · see citing works

Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and Antioxidants

Cook‐Mills, J. M., Marchese, M. E., & Abdala‐Valencia, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3522 · Cited by 597 · see citing works

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., & Ference, B. A. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3780 · Cited by 593 · see citing works

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

Sampson, M. L., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R., Sethi, A. A., Fleming, J. K., Otvos, J. D., Meeusen, J. W., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0013 · Cited by 586 · see citing works

Calcium signaling in platelets

Varga-Szabó, D., Braun, A., & Nieswandt, B. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03455.x · Cited by 575 · see citing works

Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus

Yahagi, K., Kolodgie, F. D., Lutter, C., Mori, H., Romero, M. E., Finn, A. V., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306256 · Cited by 573 · see citing works

Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance

Khamzina, L., Veilleux, A., Bergeron, S., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0921 · Cited by 562 · see citing works

Genetic and Metabolic Determinants of Plasma PCSK9 Levels

Lakoski, S. G., Lagace, T. A., Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0141 · Cited by 525 · see citing works

Hepatic uptake of chylomicron remnants

Cooper, A. D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34932-4 · Cited by 499 · see citing works

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets

Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496 · see citing works

Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention

Wong, N. D., & Sattar, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00877-z · Cited by 495 · see citing works

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Brown, W. V., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 493 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics

BURKE, A. P., Kolodgie, F. D., Zieske, A. W., Fowler, D. R., Weber, D. K., Varghese, P. J., Farb, A. A., & Virmani, R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000131783.74034.97 · Cited by 490 · see citing works

Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction

Darenskaya, M. A., Колесникова, Л. И., & Kolesnikov, S. I. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05191-7 · Cited by 488 · see citing works

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works

Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models

Kim, K., Shim, D., Lee, J. S., Zaitsev, K., Williams, J. W., Kim, K.-W., Jang, M.-Y., Seok Jang, H., Yun, T. J., Lee, S. H., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312804 · Cited by 434 · see citing works

Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription

Ishii, S., Iizuka, K., Miller, B. C., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405238101 · Cited by 416 · see citing works

Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease

Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380 · see citing works

Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ.

Vasile, E., Simionescu, M., & Simionescu, N. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.6.1677 · Cited by 364 · see citing works

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Johannesen, C. D. L., Mortensen, M. B., Langsted, A., & Nordestgaard, B. G. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.027 · Cited by 359 · see citing works

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

Wulffelé, M. G., Kooy, A., de Zeeuw, D., Stehouwer, C. D. A., & Gansevoort, R. T. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01328.x · Cited by 359 · see citing works

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

Fried, S. K., Russell, C. D., Grauso, N. L., & Brolin, R. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116821 · Cited by 356 · see citing works

Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

Witztum, J. L., Mahoney, E. M., Branks, M. J., Fisher, M., Elam, R. L., & Steinberg, D. H. (1982) · Diabetes · doi:10.2337/diab.31.4.283 · Cited by 352 · see citing works

Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 342 · see citing works

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque

Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., & Kane, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1767 · Cited by 340 · see citing works

Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media

Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334 · see citing works

Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells.

Kume, N., & Gimbrone, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117047 · Cited by 329 · see citing works

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad260 · Cited by 329 · see citing works

Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor.

Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 325 · see citing works

Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH

Schissel, S. L., Jiang, X., Tweedie-Hardman, J., Jeong, T., Hurt‐Camejo, E., Najïb, J., Rapp, J. H., Williams, K. J., & Tabas, I. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2738 · Cited by 322 · see citing works

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · see citing works

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.

Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Diabetologia · doi:10.1007/s001250050700 · Cited by 319 · see citing works

Increased Small Low-Density Lipoprotein Particle Number

Kathiresan, S., Otvos, J. D., SULLIVAN, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2005) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 317 · see citing works

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

Windler, E. E. T., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314 · see citing works

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism

Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19992 · Cited by 310 · see citing works

Glycation impairs high-density lipoprotein function

Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J. H., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310 · see citing works

Hepatic PCSK9 Expression Is Regulated by Nutritional Status via Insulin and Sterol Regulatory Element-binding Protein 1c

Costet, P., Cariou, B., Lambert, G. C., Lalanne, F., Lardeux, B. R., Jarnoux, A. L., Grefhorst, A., Staels, B., & Krempf, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508582200 · Cited by 305 · see citing works

Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells

Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305 · see citing works

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

Wang, L., Gill, R., Pedersen, T. L., Higgins, L. J., Newman, J. W., & Rutledge, J. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m700505-jlr200 · Cited by 303 · see citing works

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

Haffner, S. M., D'Agostino, R., Mykkänen, L. M., Tracy, R. P., Howard, B. V., Rewers, M., Selby, J. V., Savage, P. J., & Saad, M. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.562 · Cited by 297 · see citing works

Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.

Sadur, C. N., & Eckel, R. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110547 · Cited by 288 · see citing works

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Gordts, P. L. S. M., Nock, R., Son, N.-H., Ramms, B., Lew, I., Gonzales, J. C., Thacker, B. E., Basu, D., Lee, R. G., Mullick, A. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86610 · Cited by 274 · see citing works

Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

Adiels, M., Borén, J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Packard, C. J., & Taskinen, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172689.53992.25 · Cited by 270 · see citing works

Fasting and Postprandial Overproduction of Intestinally Derived Lipoproteins in an Animal Model of Insulin Resistance

Haidari, M., Leung, N. M., Mahbub, F., Uffelman, K. D., Avramoglu, R. K., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 269 · see citing works

Oxidation of Low-Density Lipoprotein by Hypochlorite Causes Aggregation That is Mediated by Modification of Lysine Residues Rather Than Lipid Oxidation

Hazell, L. J., van den Berg, J. J. M., & Stocker, R. (1994) · Biochemical Journal · doi:10.1042/bj3020297 · Cited by 267 · see citing works

A review of CETP and its relation to atherosclerosis

de Grooth, G. J., Klerkx, A. H. E. M., Stroes, E. S. G., Stalenhoef, A. F. H., Kastelein, J. J. P., & Kuivenhoven, J. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400007-jlr200 · Cited by 264 · see citing works

Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms

Gui, Y., Zheng, H., & Cao, R. Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.845942 · Cited by 258 · see citing works

Intracellular Trafficking and Secretion of VLDL

Tiwari, S., & Siddiqi, S. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241471 · Cited by 257 · see citing works

Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment

Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251 · see citing works

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

Ahmad, Z., Banerjee, P., Hamon, S., Chan, K., Bouzelmat, A., Sasiela, W. J., Pordy, R. C., Mellis, S. J., Dansky, H. M., Gipe, D. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.039107 · Cited by 248 · see citing works

Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.

Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240 · see citing works

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 237 · see citing works

Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance

Taghibiglou, C., Rashid-Kolvear, F., Iderstine, S. C. V., Le‐Tien, H., Fantus, I. G., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106737200 · Cited by 236 · see citing works

Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.

Chan, L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35646-1 · Cited by 231 · see citing works

Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis – Novel insights and future directions in diagnosis and therapy,

Hartley, A., Haskard, D. O., & Khamis, R. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.05.010 · Cited by 219 · see citing works

Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes

Reaven, G. M., & Greenfield, M. S. (1981) · Diabetes · doi:10.2337/diab.30.2.s66 · Cited by 214 · see citing works

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk

Tardif, J.-C., Karwatowska-Prokopczuk, E., Amour, E. S., Ballantyne, C. M., Shapiro, M. D., Moriarty, P. M., Baum, S. J., Hurh, E., Bartlett, V. J., Kingsbury, J., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab820 · Cited by 210 · see citing works

The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma

Nakajima, K., Nakano, T., & Tanaka, A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.013 · Cited by 209 · see citing works

Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS)

Sone, H., Tanaka, S., Tanaka, S., Iimuro, S., Oida, K., Yamasaki, Y., Oikawa, S., Ishibashi, S., Katayama, S., Ohashi, Y., et al. (2011) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-0622 · Cited by 201 · see citing works

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

Morgantini, C., Natali, A., Boldrini, B., Imaizumi, S., Navab, M., Fogelman, A. M., Ferrannini, E., & Reddy, S. T. (2011) · Diabetes · doi:10.2337/db11-0378 · Cited by 200 · see citing works

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

Dhindsa, D. S., Sandesara, P. B., Shapiro, M. D., & Wong, N. D. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00088 · Cited by 200 · see citing works

Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression

Williams, J. W., Zaitsev, K., Kim, K.-W., Ivanov, S., Saunders, B. T., Schrank, P. R., Kim, K., Elvington, A., Kim, S. H., Tucker, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0768-4 · Cited by 196 · see citing works

Regulation of lipid metabolism by angiopoietin-like proteins

Dijk, W., & Kersten, S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000290 · Cited by 194 · see citing works

The regulation of ApoB metabolism by insulin

Haas, M. E., Attie, A., & Biddinger, S. B. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.04.001 · Cited by 189 · see citing works

Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects

Curtiss, L. K., & Witztum, J. L. (1985) · Diabetes · doi:10.2337/diab.34.5.452 · Cited by 188 · see citing works

Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.

Hurt‐Camejo, E., Camejo, G., Rosengren, B. E., López, F., Ahlström, C., Fager, G., & Bondjers, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.5.569 · Cited by 184 · see citing works

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

Björnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183 · see citing works

Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification

Wilkins, J. T., Li, R. C., Sniderman, A., Chan, C., & Lloyd-Jones, D. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.055 · Cited by 181 · see citing works

Scavenger receptors for oxidized and glycated proteins

Horiuchi, S., Sakamoto, Y., & Sakai, M. (2003) · Amino Acids · doi:10.1007/s00726-003-0029-5 · Cited by 175 · see citing works

A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis

Armstrong, S. M., Sugiyama, M. G., Fung, K., Gao, Y. K., Wang, C., Levy, A. S., Azizi, P., Roufaiel, M., Zhu, S.-N., Neculai, D., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv218 · Cited by 172 · see citing works

Localization of Nonpancreatic Secretory Phospholipase A 2 in Normal and Atherosclerotic Arteries

Hurt‐Camejo, E., Andersen, S. B., Standal, R., Rosengren, B. E., Sartipy, P., Stadberg, E., & Johansen, B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.300 · Cited by 170 · see citing works

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

Sundaram, M., Zhong, S., Khalil, M. B., Links, P. H., Zhao, Y., Iqbal, J., Hussain, M. M., Parks, R. J., Wang, Y., & Yao, Z. (2009) · Journal of Lipid Research · doi:10.1194/m900346-jlr200 · Cited by 170 · see citing works

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity

Rabbani, N., Godfrey, L., Xue, M., Shaheen, F., Geoffrion, M., Milne, R. W., & Thornalley, P. J. (2011) · Diabetes · doi:10.2337/db11-0085 · Cited by 167 · see citing works

The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis

Summerhill, V. I., Grechko, A. V., Yet, S., Sobenin, I. A., & Orekhov, A. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143561 · Cited by 167 · see citing works

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

Kazé, A. D., Santhanam, P., Musani, S. K., Ahima, R. S., & Echouffo-Tcheugui, J. B. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.016947 · Cited by 167 · see citing works

Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice

Ai, D., Chen, C., Han, S., Ganda, A., Murphy, A. J., Haeusler, R. A., Thorp, E. B., Accili, D., Horton, J. D., & Tall, A. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61919 · Cited by 165 · see citing works

Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans

Hurt‐Camejo, E., Olsson, U., Wiklund, O., Bondjers, G., & Camejo, G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1011 · Cited by 165 · see citing works

Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans

Xiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.246207 · Cited by 164 · see citing works

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C

Pencina, M. J., D’Agostino, R. B., Zdrojewski, T., Williams, K., Thanassoulis, G., Furberg, C. D., Peterson, E. D., Vasan, R. S., & Sniderman, A. D. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315569411 · Cited by 164 · see citing works

Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia

Caron, S., Verrijken, A., Mertens, I. L., Samanez, C. H., Mautino, G., Haas, J. T., Duran-Sandoval, D., Prawitt, J., Francque, S., Vallez, E., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.220723 · Cited by 162 · see citing works

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

Hurt‐Camejo, E., Camejo, G., Rosengren, B. E., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162 · see citing works

Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)

Lee, E.-C., Desai, U., Gololobov, G., Hong, S., Feng, X., Yu, X., Gay, J. P., Wilganowski, N., Gao, C., Du, L.-L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807899200 · Cited by 161 · see citing works

Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells

Kraehling, J. R., Chidlow, J. H., Rajagopal, C., Sugiyama, M. G., Fowler, J. W., Lee, M. Y., Zhang, X., Ramírez, C. M., Park, E. J., Tao, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms13516 · Cited by 159 · see citing works

Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits

Nordestgaard, B. G., & Zilversmit, D. B. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38428-5 · Cited by 156 · see citing works

Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B

McNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147 · see citing works

Postprandial Hyperlipidemia and Remnant Lipoproteins

Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145 · see citing works

Oxidized Low Density Lipoprotein and Lysophosphatidylcholine Stimulate Cell Cycle Entry in Vascular Smooth Muscle Cells

Chai, Y.-C., Howe, P. H., DiCorleto, P. E., & Chisolm, G. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17791 · Cited by 142 · see citing works

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Hiukka, A., Ståhlman, M., Pettersson, C., Levin, M. C., Adiels, M., Teneberg, S., Leinonen, E. S., Hultén, L. M., Wiklund, O., Orešič, M., et al. (2009) · Diabetes · doi:10.2337/db09-0206 · Cited by 141 · see citing works

Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Sniderman, A. D., Islam, S., Yusuf, S., & McQueen, M. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.039 · Cited by 138 · see citing works

Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles

Öörni, K., Hakala, J. K., Annila, A., Ala‐Korpela, M., & Kovanen, P. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29127 · Cited by 137 · see citing works

Impact of advanced glycation end products (AGEs) signaling in coronary artery disease

Kosmopoulos, M., Drekolias, D., Zavras, P. D., Piperi, C., & Papavassiliou, A. G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.006 · Cited by 136 · see citing works

Lysophosphatidylcholine Promotes P-Selectin Expression in Platelets and Endothelial Cells

Murohara, T., Scalia, R. G., & Lefer, A. M. (1996) · Circulation Research · doi:10.1161/01.res.78.5.780 · Cited by 132 · see citing works

Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation

Ahmad, S., Khan, M. S., Akhter, F., Khan, M. S., Khan, M. S., Ashraf, J. M., Pandey, R. P., & Shahab, U. (2014) · Glycobiology · doi:10.1093/glycob/cwu057 · Cited by 131 · see citing works

Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis

Fogelstrand, P., & Borén, J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.09.007 · Cited by 127 · see citing works

New insight into the pathophysiology of lipid abnormalities in type 2 diabetes

Vergès, B. L. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70213-6 · Cited by 126 · see citing works

Intimal Retention of Cholesterol Derived From Apolipoprotein B100– and Apolipoprotein B48–Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits

Proctor, S. D., & Mamo, J. C. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000084638.14534.0a · Cited by 124 · see citing works

Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.

Lenten, B. J. V., Fogelman, A. M., Jackson, R. L., Shapiro, S., Haberland, M. E., & Edwards, P. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39420-6 · Cited by 122 · see citing works

A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)

Jani, R. H., Pai, V., Jha, P. R., Jariwala, G., Mukhopadhyay, S., Bhansali, A. K., & Joshi, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0253 · Cited by 118 · see citing works

Lipid modification in type 2 diabetes: the role of LDL and HDL

Vergès, B. (2009) · Fundamental &amp; Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00739.x · Cited by 117 · see citing works

Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans

Vedala, A., Wang, W., Neese, R. A., Christiansen, M. P., & Hellerstein, M. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600200-jlr200 · Cited by 117 · see citing works

A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)

Pai, V., Paneerselvam, A., Mukhopadhyay, S., Bhansali, A. K., Kamath, D., Shankar, V., Gambhire, D., Jani, R. H., Joshi, S., & Patel, P. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813518680 · Cited by 115 · see citing works

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan

Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200322-jlr200 · Cited by 114 · see citing works

Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

Srivastava, R. A. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3165-z · Cited by 111 · see citing works

Oxford Textbook of Endocrinology and Diabetes

LATROFA, F., VITTI, P., & PINCHERA, A. (2011) · doi:10.1093/med/9780199235292.001.1 · Cited by 111 · see citing works

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

BRIONES, E. R., Mao, S. J. T., Palumbo, P. J., O’Fallon, W. M., CHENOWETH, W. L., & Kottke, B. A. (1984) · Metabolism · doi:10.1016/0026-0495(84)90160-4 · Cited by 107 · see citing works

Identification of the Proteoglycan Binding Site in Apolipoprotein B48

Flood, C., Gustafsson, M. V., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 107 · see citing works

Lysophosphatidyl Choline, a Chemotactic Factor for Monocytes/T-Lymphocytes Is Elevated in Endometriosis

Murphy, A. A., Santanam, N., Morales, A. J., & Parthasarathy, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4823 · Cited by 107 · see citing works

Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein

Aviram, M., Rosenblat, M., Etzioni, A., & Lévy, R. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90005-0 · Cited by 105 · see citing works

RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts

Watts, G. F., Schwabe, C., Scott, R., Gladding, P. A., Sullivan, D., Baker, J., Clifton, P., Hamilton, J., Given, B., Melquist, S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02494-2 · Cited by 105 · see citing works

Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women

Lawler, P. R., Akinkuolie, A. O., Ridker, P. M., Sniderman, A. D., Buring, J. E., Glynn, R. J., Chasman, D. I., & Mora, S. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.264515 · Cited by 104 · see citing works

Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro

Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104 · see citing works

Arterial Permeability and Efflux of Apolipoprotein B–Containing Lipoproteins Assessed by In Situ Perfusion and Three-Dimensional Quantitative Confocal Microscopy

Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143859.75035.5a · Cited by 103 · see citing works

Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice

Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y. K., Ramakrishnan, R., Goldberg, I. J., & Shachter, N. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8283 · Cited by 103 · see citing works

Glycation as an atherogenic modification of LDL

Younis, N. N., Sharma, R., Soran, H., Charlton-Menys, V., Elseweidy, M. M., & Durrington, P. N. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306a057 · Cited by 102 · see citing works

Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients

Rabini, R. A., Galassi, R., Fumelli, P., Dousset, N., Solera, M. L., Valdiguié, P. M., CURATOLA, G., Ferretti, G., Taus, M., & Mazzanti, L. (1994) · Diabetes · doi:10.2337/diab.43.7.915 · Cited by 102 · see citing works

Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages

Iwashima, Y., Eto, M., Hata, A., Kaku, K., Horiuchi, S., Ushikubi, F., & Sano, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3685 · Cited by 101 · see citing works

Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance

Laatsch, A., Merkel, M., Talmud, P. J., Grewal, T., Beisiegel†, U., & Heeren, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.046 · Cited by 100 · see citing works

Glycated Low Density Lipoproteins Modify Platelet Properties: A Compositional and Functional Study

Ferretti, G., Rabini, R. A., Bacchetti, T., Vignini, A., Salvolini, E., Ravaglia, F., CURATOLA, G., & Mazzanti, L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8466 · Cited by 99 · see citing works

Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects.

Tames, F., Mackness, M., Arrol, S., Laing, I., & Durrington, P. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90260-n · Cited by 98 · see citing works

Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins.

Chung, B. H., Tallis, G. A., Yalamoori, V., Anantharamaiah, G. M., & Segrest, J. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.622 · Cited by 97 · see citing works

Effects of <i>APOC3</i> Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

Reyes-Soffer, G., Sztalryd, C., Horenstein, R. B., Holleran, S., Matveyenko, A., Thomas, T., Nandakumar, R., Ngai, C., Karmally, W., Ginsberg, H. N., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311476 · Cited by 97 · see citing works

‘Lipoproteins, glycoxidation and diabetic angiopathy’

Jenkins, A. J., Best, J. D., Klein, R. L., & Lyons, T. J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.491 · Cited by 96 · see citing works

Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes

Vergès, B. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.028 · Cited by 95 · see citing works

Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction

Meuwissen, M., van der Wal, A. C., Niessen, H. W. M., Koch, K. T., de Winter, R. J., van der Loos, C. M., Rittersma, S. Z. H., Chamuleau, S. A. J., Tijssen, J. G. P., Becker, A. E., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027235 · Cited by 94 · see citing works

New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk

Kersten, S. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000600 · Cited by 94 · see citing works

Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor

Olsson, U., Camejo, G., Hurt-Camejo, E., Elfsber, K., Wiklund, O., & Bondjers, G. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.149 · Cited by 94 · see citing works

Expression of Class A Scavenger Receptor Is Enhanced by High Glucose in Vitro and under Diabetic Conditions in Vivo

Takaki, K., Sakai, M., Sakamoto, Y.-I., Takeya, M., & Horiuchi, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408715200 · Cited by 91 · see citing works

Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellS

Florén, C., Albers, J. J., & Bierman, E. L. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90219-8 · Cited by 90 · see citing works

Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes

Kashyap, S. R., Ösme, A., Ilchenko, S., Golizeh, M., Lee, K., Wang, S., Bena, J., Previs, S. F., Smith, J. D., & Kasumov, T. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01551 · Cited by 90 · see citing works

Susceptibility of LDL and its subfractions to glycation

Soran, H., & Durrington, P. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328348a43f · Cited by 89 · see citing works

Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia

Lu, X., Perrard, X. D., Perrard, J. L., Yang, D., Xiao, X., Teng, B.-B., Simon, S. I., Ballantyne, C. M., & Wu, H. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305609 · Cited by 89 · see citing works

Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis

Marcovecchio, P., Thomas, G. D., Mikulski, Z., Ehinger, E., Mueller, K. A. L., Blatchley, A., Wu, R., Miller, Y. I., Nguyen, A. T., Taylor, A. M., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309123 · Cited by 87 · see citing works

Binding of Human Phospholipase A2 Type II to Proteoglycans

Sartipy, P., Johansen, B., Camejo, G., Rosengren, B. E., Bondjers, G., & Hurt‐Camejo, E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26307 · Cited by 86 · see citing works

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Wadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2023) · Diabetologia · doi:10.1007/s00125-023-06016-0 · Cited by 86 · see citing works

Pathophysiology of type 1 diabetes mellitus

Kolb, H. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212158 · Cited by 85 · see citing works

Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin

Haridas, P. A. N., Soronen, J., Sädevirta, S., Mysore, R., Quagliarini, F., Pasternack, A. H., Metso, J., Perttilä, J., Leivonen, M., Smas, C. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1254 · Cited by 83 · see citing works

Role of Group IIa and Group V Secretory Phospholipases A2 in the Metabolism of Lipoproteins. Substrate Specificities of the Enzymes and the Regulation of Their Activities by Sphingomyelin

Gesquiere, L. R., Cho, W., & Subbaiah, P. V. (2002) · Biochemistry · doi:10.1021/bi015757x · Cited by 82 · see citing works

Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

Kissebah, A. H., Alfarsi, S., Evans, D. J., & Adams, P. W. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110812 · Cited by 82 · see citing works

Glucosylated Glycerophosphoethanolamines are the Major LDL Glycation Products and Increase LDL Susceptibility to Oxidation

Ravandi, A., Kuksis, A., & Shaikh, N. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.467 · Cited by 81 · see citing works

Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid

Hernandez, C., Molusky, M. M., Li, Y., Li, S., & Lin, J. D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.001 · Cited by 79 · see citing works

Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy

Duvillard, L., Florentin, E., Lizard, G., Petit, J., Galland, F., Monier, S., Gambert, P., & Vergès, B. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1540 · Cited by 79 · see citing works

Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor

Shimamura, M., Matsuda, M., Ando, Y., Koishi, R., Yasumo, H., Furukawa, H., & Shimomura, I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.024 · Cited by 78 · see citing works

Glycation Accelerates the Oxidation of Low Density Lipoprotein by Copper Ions.

Kobayashi, K., WATANABE, J., Umeda, F., & Nawata, H. (1995) · Endocrine Journal · doi:10.1507/endocrj.42.461 · Cited by 78 · see citing works

Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells

Brown, B. E., Dean, R. T., & Davies, M. J. (2005) · Diabetologia · doi:10.1007/s00125-004-1648-4 · Cited by 77 · see citing works

Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans

Maeda, S., Nakanishi, S., Yoneda, M., Awaya, T., Yamane, K., Hirano, T., & Kohno, N. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11445 · Cited by 76 · see citing works

Uptake of Remnant Like Particles (RLP) in Diabetic Patients from Mouse Peritoneal Macrophages

Tomono, S., Kawazu, S., Kato, N., Ono, T., Ishii, C., Ito, Y., Shimizu, M., Shimoyama, M., Nakano, T., & Nakajima, K. (1994) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.1.98 · Cited by 76 · see citing works

Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells

Zhang, J., Ren, S., Sun, D., & Shen, G. X. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1140 · Cited by 76 · see citing works

Lipid-lowering in diabetes: An update

Chait, A., Eckel, R. H., Vrablı́k, M., & Zambon, A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117313 · Cited by 71 · see citing works

RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia

Gaudet, D., Clifton, P., Sullivan, D., Baker, J., Schwabe, C., Thackwray, S., Scott, R., Hamilton, J., Given, B., Melquist, S., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200325 · Cited by 71 · see citing works

The Classification and Diagnosis of Diabetes Mellitus

Alberti, K. G. M. M. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch2 · Cited by 68 · see citing works

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques

Imanaga, Y., Sakata, N., Takebayashi, S., Matsunaga, A., Sasaki, J., Arakawa, K., Nagai, R., Horiuchi, S., Itabe, H., & Takano, T. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00396-2 · Cited by 65 · see citing works

Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans.

Camejo, G., Hurt‐Camejo, E., Rosengren, B. E., Wiklund, O., López, F., & Bondjers, G. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41901-7 · Cited by 65 · see citing works

Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes

Younis, N. N., Soran, H., Pemberton, P. W., Charlton-Menys, V., Elseweidy, M. M., & Durrington, P. N. (2012) · Clinical Science · doi:10.1042/cs20120304 · Cited by 64 · see citing works

The extracellular matrix on atherogenesis and diabetes-associated vascular disease

Camejo, G., Olsson, U., Hurt‐Camejo, E., Baharamian, N., & Bondjers, G. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00005-8 · Cited by 63 · see citing works

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance

Yilmaz, Y. N., Ulukaya, E., Atuğ, Ö., & Dolar, E. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832b77ae · Cited by 63 · see citing works

Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose

Toma, L., Stancu, C. S., Botez, G. M., Sima, A. V., & Simionescu, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.066 · Cited by 62 · see citing works

The pathophysiology of intestinal lipoprotein production

Giammanco, A., Cefalu, A. B., Noto, D., & Averna, M. R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00061 · Cited by 61 · see citing works

Regulation of low‐density‐lipoprotein‐receptro mRNA by insulin in human hepatoma Hep G2 cells

Wade, D. P., Knight, B. L., & Soutar, A. K. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14784.x · Cited by 61 · see citing works

Induction of macrophage growth by advanced glycation end products of the Maillard reaction.

Yui, S., Sasaki, T., Araki, N., Horiuchi, S., & Yamazaki, M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1943 · Cited by 61 · see citing works

Metabolic Syndrome and Diabetic Atherothrombosis: Implications in Vascular Complications

Meerarani, P., Badimón, J. J., Zias, E. A., Fuster, V., & Moreno, P. (2006) · Current Molecular Medicine · doi:10.2174/156652406778018680 · Cited by 60 · see citing works

Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation

Whitman, S. C., Miller, D. B., Wolfe, B. M., Hegele, R. A., & Huff, M. W. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1707 · Cited by 59 · see citing works

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance

Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59 · see citing works

Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy

Viberti, G. C. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90257-7 · Cited by 58 · see citing works

AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway

Shu, M., Cheng, W., Jia, X., Bai, X., Zhao, Y., Lu, Y., Zhu, L., Zhu, Y. S., Wang, L., Shu, Y., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00715-5 · Cited by 58 · see citing works

Proteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis

Tannock, L. R., & King, V. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9078-0 · Cited by 57 · see citing works

Type 2 Diabetes in Mice Induces Hepatic Overexpression of Sulfatase 2, a Novel Factor That Suppresses Uptake of Remnant Lipoproteins

Chen, K., Liu, M., Schaffer, L., Li, M., Boden, G. H., Wu, X., & Williams, K. J. (2010) · Hepatology · doi:10.1002/hep.23916 · Cited by 56 · see citing works

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

Scott, R. S., Donoghoe, M. W., Watts, G. F., O’Brien, R. C., Pardy, C. J., Taskinen, M., Davis, T. M. E., Colman, P. G., Manning, P. J., Fulcher, G. R., et al. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-102 · Cited by 56 · see citing works

Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia

Adiels, M., Taskinen, M., Björnson, E., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Hakkarainen, A., Lundbom, N., Sihlbom, C., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13744 · Cited by 55 · see citing works

Involvement of RAGE, NADPH Oxidase, and Ras/Raf-1 Pathway in Glycated LDL-Induced Expression of Heat Shock Factor-1 and Plasminogen Activator Inhibitor-1 in Vascular Endothelial Cells

Sangle, G. V., Zhao, R., Mizuno, T. M., & Shen, G. X. (2010) · Endocrinology · doi:10.1210/en.2010-0323 · Cited by 55 · see citing works

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus

Bonilha, I., Hajduch, É., Luchiari, B., Nadruz, W., Goff, W. L., & Sposito, A. C. (2021) · Metabolites · doi:10.3390/metabo11120807 · Cited by 55 · see citing works

Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial Cells

Iwashima, Y., Eto, M., Horiuchi, S., & Sano, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1539 · Cited by 53 · see citing works

Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis

Isoda, K., Folco, E. J. E., Marwali, M. R., Ohsuzu, F., & Libby, P. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.035 · Cited by 53 · see citing works

Glycated Phosphatidylethanolamine Promotes Macrophage Uptake of Low Density Lipoprotein and Accumulation of Cholesteryl Esters and Triacylglycerols

Ravandi, A., Kuksis, A., & Shaikh, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16494 · Cited by 52 · see citing works

Diabetes alters LDL receptor and PCSK9 expression in rat liver

Niesen, M. I., Bedi, M., & Lopez, D. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.11.009 · Cited by 51 · see citing works

Intestinal lipid absorption and transport in type 2 diabetes

Vergès, B. L. (2022) · Diabetologia · doi:10.1007/s00125-022-05765-8 · Cited by 51 · see citing works

Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies

Li, D., Devaraj, S., Fuller, C., Bucala, R., & Jialal, I. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37563-5 · Cited by 50 · see citing works

Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats

Tolbus, A., Mortensen, M. B., Nielsen, S. F., Kamstrup, P. R., Bojesen, S. E., & Nordestgaard, B. G. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277103 · Cited by 50 · see citing works

Glycolaldehyde-Modified Low Density Lipoprotein Leads Macrophages to Foam Cells via the Macrophage Scavenger Receptor

Jinnouchi, Y., Sano, H., Nagai, R., Hakamata, H., Kodama, T., Suzuki, H., Yoshida, M., Ueda, S., & Horiuchi, S. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022062 · Cited by 48 · see citing works

Metabolic syndrome

Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463 · see citing works

Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk

Berisha, H., Hattab, R., Comi, L., Giglione, C., Migliaccio, S., & Magni, P. (2025) · Nutrients · doi:10.3390/nu17050776 · Cited by 75 · see citing works

The link between diabetes and cardiovascular disease

Borén, J., Öörni, K., & Catapano, A. L. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117607 · Cited by 44 · see citing works

[Incisional hernia after surgery for abdominal aortic aneurysm].

Augestad, K. M., Wilsgaard, T., & Solberg, S. K. (2002) · PubMed · Cited by 29 · see citing works

Association of insulin resistance-related indicators with cardiovascular disease in Chinese people with different glycemic states

Zhang, Z., & Tan, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1515559 · Cited by 25 · see citing works

Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease

Burks, K. H., Stitziel, N. O., & Davidson, N. O. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101409 · Cited by 22 · see citing works

Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes

Elías-López, D., Wadström, B. N., Vedel‐Krogh, S., Kobylecki, C. J., & Nordestgaard, B. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01555-1 · Cited by 18 · see citing works

Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia

Herdiana, Y., Levita, J., & Jiranusornkul, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s517492 · Cited by 15 · see citing works

Spatial analysis of air pollutant exposure and its association with metabolic diseases using machine learning

Liu, J., Liu, C., Liu, Z., Zhou, Y., Li, X., & Yang, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-22077-9 · Cited by 12 · see citing works

Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems

Kiss, I., Neuwert, N., Oberle, R., Hengstschläger, M., Osmanagic-Myers, S., & Stangl, H. (2025) · Biomolecules · doi:10.3390/biom15070956 · Cited by 11 · see citing works

Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications

Zubirán, R., Cruz‐Bautista, I., & Aguilar-Salinas, C. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01626-2 · Cited by 11 · see citing works

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular disease mortality in patients with type 2 diabetes mellitus and diabetic kidney disease

Li, Z., & Xu, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1509752 · Cited by 9 · see citing works

Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

Rikhi, R. R., Haidar, A., Bhatia, H. S., Beam, K., McParland, J., Kazibwe, R., Chevli, P. A., Schaich, C. L., Sanghavi, M., & Shapiro, M. D. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119179 · Cited by 9 · see citing works

The Obesity Paradox of Cardiovascular Outcomes in Patients with Diabetes Mellitus

Thakker, J., Khaliq, I., Ardeshna, N. S., Lavie, C. J., & Oktay, A. A. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01592-4 · Cited by 9 · see citing works

Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis

Cai, X., Xu, X., He, G., Jiang, X., & Wu, L. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09712-3 · Cited by 9 · see citing works

Ratio of remnant cholesterol to high-density lipoprotein cholesterol in relation to gestational diabetes mellitus risk in early pregnancy among Korean women

Sheng, J., Ma, C., Wu, X., & Li, X.-X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316934 · Cited by 6 · see citing works

Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine

Radomska-Leśniewska, D. M., Niderla‐Bielińska, J., Kujawa, M., & Jankowska-Steifer, E. A. (2025) · Metabolites · doi:10.3390/metabo15100645 · Cited by 5 · see citing works

Effects of Rice Bran Supplementation on Metabolic Syndrome-Related Parameters: A Systematic Review and Meta-Analysis

Tantayakhom, S., Inpan, R., Yaja, K., Koonrungsesomboon, N., Teekachunhatean, S., & Takuathung, M. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189051 · Cited by 4 · see citing works

SdLDL‑C/LDL‑C discordance as a practical surrogate for triglyceride‑associated cardiovascular risk: identification of at‑risk lipid phenotypes in the CHARLS prospective cohort

Xue, Y., Luo, J., Yang, X., Ren, Z., Fan, H., Luo, W., & Liang, B. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02925-2 · Cited by 4 · see citing works

Analysis of Metabolic Risk Factors for Microcirculation Disorders Post-Percutaneous Coronary Intervention and Predictive Model Construction: A Study on Patients with Unstable Angina

Li, K., Liu, S., Wang, J., Liu, Z., & Qi, C. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25739 · Cited by 4 · see citing works

Quercetin as an Anti-Diabetic Agent in Rodents—Is It Worth Testing in Humans?

Szkudelski, T., Szkudelska, K., & Łangowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157391 · Cited by 3 · see citing works

The association between HbA1c/HDL-C and the incidence of cardiometabolic multimorbidity in middle-aged and elderly adults: Results from the China Health and Retirement Longitudinal Study

Zeng, Y., Lin, L., Zheng, W., & Chen, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332376 · Cited by 3 · see citing works

Association of remnant cholesterol with stroke risk by glycemic status: a nationwide prospective cohort study

Lu, F., & Yang, F. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113190 · Cited by 3 · see citing works

Lipoprotein(a) and Vascular Redox State in Patients With Advanced Coronary Atherosclerosis

Polkinghorne, M., Badi, I., Baragetti, A., Chauhan, J. S., Xie, C., Wahome, E., Akoumianakis, I., Foran, D., Patel, P., de Araujo, E., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322924 · Cited by 3 · see citing works

The Functional Interaction Between PRDM16 and the SREBP Pathway Controls Lipid Metabolism

Mahmood, H. M., Bengoechea-Alonso, M. T., Al-Ansari, D. E., Machaca, K., & Ericsson, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110246 · Cited by 2 · see citing works

Molecular Hybridization Strategy for Developing Lipid‐Lowering Compounds: Design and Synthesis of Vanillin‐Based Fibrate Derivatives

Xu, K., Li, W., Zhou, B., Zhang, Y., Shi, H., Ding, L., Shangguan, H., Liu, J., Shi, Y., & Xie, Y. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502843 · Cited by 2 · see citing works

Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease

Davidson, N. O. (2026) · Circulation Research · doi:10.1161/circresaha.126.327269 · Cited by 2 · see citing works

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases

Mangoni, A. A., Hulin, J.-A., & Tommasi, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100147 · Cited by 2 · see citing works

non-HDL-C: The missing parameter in primary care

Baeza-Delgado, C., Saurí, I., Diaz, J., Fernández, A., Forner, M. J., Martínez, F., Martinez, S., & Redón, J. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107063 · Cited by 2 · see citing works

Targeting Apolipoprotein C-III for the Management of Severe Hypertriglyceridemia: Current Research and Future Directions

Shah, M. A., Sharma, A., Ayyad, M., Swartz, E., Jafrani, D., & Gala, D. (2024) · Cureus · doi:10.7759/cureus.67091 · Cited by 2 · see citing works

Changes in liver function markers and lipid profile of rats administered rainy and dry season Amaranthus spinosus methanol extract and lead acetate

Isoje, E. F., Okoro, I. O., Apiamu, A., & Okpoghono, J. (2025) · Food Chemistry Advances · doi:10.1016/j.focha.2025.101049 · Cited by 1 · see citing works

Clinical value of dyslipidemia and glycemic variability for progression to dementia in type 2 diabetes mellitus-associated mild cognitive impairment

Liu, G., Li, S., Qi, X., Wang, X., Wang, M., Li, Q., Cui, L., Yue, H., Liu, F., & Lin, Y. (2025) · Neurogenetics · doi:10.1007/s10048-025-00859-y · Cited by 1 · see citing works

Insulin resistance and its association with coronary heart disease: insights from bioinformatics analysis

Lu, X., Liu, M., Song, Y., Lin, S., Zhou, X., Zeng, H., Li, A., Li, H., Xie, X., Lin, S., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1730801 · Cited by 1 · see citing works

Simultaneous Bilateral Renal Revascularization in an Elderly Patient With Recurrent Flash Pulmonary Edema: A Case Report

Neto, A. T. D. M. F., Bento, G. V. J. T., Azevedo, L., Rodrigues, I. M., Luiz, J. S., Campos, J. P. F., Morisson, L. G. A., O’Connell, J. L., Silva, B. M., & Silva, T. M. (2026) · Cureus · doi:10.7759/cureus.101079 · Cited by 1 · see citing works

Diagnosis of Antipsychotic Medication‐Induced Severe Hypertriglyceridaemia by the Phenomenon of Pseudohyponatraemia and Successful Management With Variable‐Rate Intravenous Insulin Infusion: A Case Report

Coleman, A., Kettyle, G., Monaghan, M., & McKeever, E. (2026) · Case Reports in Endocrinology · doi:10.1155/crie/2376136 · Cited by 1 · see citing works

Hypocaloric low-carbohydrate versus low-fat diets on flow-mediated dilation, blood pressure, cardiovascular biomarkers, and body composition in individuals with overweight or obesity: a systematic review and meta-analysis of randomized clinical trials

Kazeminasab, F., Baharlooie, M., Bagheri, R., Rosenkranz, S. K., & Santos, H. O. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01626-w · Cited by 1 · see citing works

Knowledge, Attitudes, and Practices of Elderly Diabetic Patients and Their Families Regarding Comorbid Non-Alcoholic Fatty Liver Disease: A Structural Equation Modeling Analysis

Wang, Q., Zhang, Y., Guo, X., & Zhao, L. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s541709 · Cited by 1 · see citing works

In situ delipidation-based structure of low-density lipoprotein and apolipoprotein B-100 physiologically imaged by atomic force microscopy

Wang, K., Qin, Y., Jiang, X.-C., & Chen, Y. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151070 · Cited by 1 · see citing works

Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome

Dhalla, N. S., Patel, C. A., Beladiya, J., Mehta, A. A., & Gandhi, T. R. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.04.007 · Cited by 1 · see citing works

Therapeutic potential of natural compounds from medicinal and food homology substances targeting gut microbiota in lipid metabolism disorders

Xia, Q., Xin, J., Mu, Y., Li, M., Yao, J., Xiao, X., Wang, X. L., & Gang, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1809114 · Cited by 1 · see citing works

Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials

Wu, X., Yang, Y., Cui, X., Li, X., & Li, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1846714 · Cited by 1 · see citing works

An integrative analysis of elementomics and oxidation-reduction potentials identifies redox-related metals associated with coronary artery disease and post-PCI outcomes in type 2 diabetic patients

Fang, Z.-Q., Wang, B., Cui, N., Zhe-zhe, Y., & Wang, X. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104270 · Cited by 1 · see citing works

4D-DIA-based proteomics analysis reveals the protective effects of Pidanjiangtang granules in IGT rat model

Xie, Y., Fan, Y., Liu, X., Li, Z., & Liu, S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119012 · Cited by 1 · see citing works

Targeting triglycerides for cardiovascular risk reduction

Maiorca, C., Tramontano, D., Di Costanzo, A., & D’Erasmo, L. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04383-1

Evaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease

Parichehreh-Dizaji, S., Hosseini, S. K., Dayani, S. B., Maghsoudi, H., Esmaily, F., & Amoli, M. M. (2024) · GenoMed Connect · doi:10.69709/genomc.2024.116041

Genetics of Lp(a) and association with cardiovascular risk

Flores, C. F. Y., & Cabrera, A. T. M. (2025) · Bionatura journal : · doi:10.70099/bj/2025.02.01.4

Evaluation of the role of lipid profile and kidney function in men with type 2 diabetes in the city of Kirkuk

Hameed, S. M., & Abdulrahman, S. J. (2025) · International Journal of Life Science Research Archive · doi:10.53771/ijlsra.2025.8.2.0031

Interaktion von Fettstoffwechselstörungen und Diabetes mellitus: Therapeutische Implikation

Baumgartner, I. (2025) · Gefässchirurgie · doi:10.1007/s00772-025-01196-y

La Comida y la Salud. Que tu Alimento sea tu Propia Medicina

Tirado, J. D. T., Gutiérrez, J. L. C., Pérez-García, L. A., & Pérez‐Flores, G. (2025) · TLATEMOANI Revista Académica de Investigación · doi:10.51896/tlatemoani.v16i48.845

The “SMART” side of hypertriglyceridemia

Cabezas, M. C., & Klop, B. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120467

Calculated small-dense and large-buoyant low-density lipoprotein-cholesterol and their ratio in predicting coronary artery disease risk: A cohort study in Thailand

Chantivas, T., Vathesatogkit, P., Chittamma, A., Thongmung, N., Kroll, M. H., & Srisawasdi, P. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.111018

Lipoprotein(a) and Small Dense LDL Profiles and Statin Response in Type 2 Diabetes Mellitus: A Case-Control StudyPreprint

Suta, S., Pinsawas, B., Surawit, A., Ophakas, S., Wang, Y., Du, Y. Y., Shen, X., Pasookhush, P., Mongkolsucharitkul, P., Soonkum, T., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7577991/v1

Gender differences in the distribution of IDL, LDL, and HDL lipoprotein subfractions in MODY compared to type 2 diabetes: Data from the MODY-Ist study

Yılmaz, H., Demirci, D. K., Gül, N., Yanar, F., Poyrazoğlu, Ş., Yılmaz, S. G., Tüzüner, M. B., İşbir, T., Öztürk, O., & Satman, İ. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109196

Multi-omics Integration with GWAS Unveils Molecular Mechanistic Insights for Type 2 DiabetesPreprint

Abbas, M., Toh, H., Martin, P. M., Lindsey, M. L., Melese, M. T., Oteng, A., & Gaye, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.21.689764

Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients

Heerkens, L., Gonzales, G. B., Geleijnse, J. M., & van Duijnhoven, F. J. B. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104535

Distinct compositional alterations in plasma lipoproteins in type 2 diabetes: a cross-sectional study of healthy individuals and diabetics with and without cardiovascular comorbidities

Tsay, E., Kurmaeva, D., Nuriddinov, S., Tsoy, V., Abduxalimova, S., Bozorov, S. S., Khalimova, Z., Engelsen, S. B., Magkos, F., Akbarovna, D. D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03039-2

Distribution of ApoE Gene Polymorphism and Its Association with the Lipid Profile Among Type 2 Diabetes Mellitus Black South Africans

Mkhwanazi, S., Mapheto, T. J., Mkhondo, H. B., Majane, O. H. I., Gololo, S. S., & Nemukula, M. (2026) · Diabetology · doi:10.3390/diabetology7010008

Association between ApoA1, ApoB, and the ApoB/ApoA1 ratio with the risk of diabetic neuropathy: A systematic review and meta-analysis

Gosal, E., Djuartina, T., Sutrisno, A., & Budianto, I. R. (2025) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol16.iss2.art12

Multimodal Echocardiography for Diagnostic Value of Type 2 Diabetes Mellitus Complicated with Left Anterior Descending Artery Stenosis: A Retrospective Case-Control Study

Li, Z., Wu, J., You, J., He, Z., Wang, L., Zhou, X., & Hu, G. (2026) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/0115734056410845251205082610

Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations

REIS, A. C., Araújo, A. R. D., Dias, I. H. K., Antonny, B., Pérez, A., Sánchez‐Quesada, J. L., & de Freitas, V. A. P. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110780

Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease Revealed by Multi-Omics Integration and Mendelian Randomization

Zhai, M., Bai, F., Yan, R., & Liu, M. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-1057

Association of Blood Lipid Markers and 20-year Cardiovascular Disease Incidence: The ATTICA Epidemiological Cohort Study (2002–2022)

Lagou, S., Barkas, F., Giannakopoulou, S., Koutsogianni, A.-D., Adamidis, P. S., Anastasiou, G., Kyrili, K., Chrysohoou, C. A., Tsioufis, C., Pitsavos, C., et al. (2025) · Journal of Atherosclerosis Prevention and Treatment · doi:10.4103/aptj.aptj_4_25

Enhanced independent discriminative performance of elevated lipoprotein(a) for cardiovascular outcomes in patients with diabetes: a comparative analysis of optimal cutoff values

Wen, S., He, Y., Li, X. I. A. O., Xu, Z., Liu, D., Li, J., & Zhou, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1795181

Development and external validation of an interpretable machine learning model for diagnosing coronary heart disease in patients with type 2 diabetes and MASLD

Deng, C., Feng, L., Li, T., Wei, S., Zhu, H., & Lu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1830594

Research Progress of Pancreatic β-Cell Autophagy in Diabetes

Zhang, X. (2026) · Theoretical and Natural Science · doi:10.54254/2753-8818/2026.33552

Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study

Rong, L., Fan, H.-D., Fang, Q., Li, X., Tan, J., & Huang, J. (2026) · Medicine · doi:10.1097/md.0000000000049157

Inflammation in atherosclerosis: Drivers, mechanisms and therapies

Su, Z., & Xu, S. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.047

The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States

Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1849520

Fermented Musa paradisica fruit pulp extract attenuates dyslipidemia, and pancreatic, jejunal and neuronal dysfunctions in streptozotocin-induced diabetes in rats

Atunnise, A., Awoniran, P. G., Adebayo, O. L., Adewuyi, A., & Salau, B. A. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100527

From fructose to steatosis, fructose-induced inflammation as a driver of hepatic injury and MAFLD progression: a systematic review of preclinical studies

Arifin, M., Jannah, W., Latarissa, I. R., Zakiyah, N., Meiliana, A., Barliana, M. I., & Lestari, K. (2026) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2025-001416

Type 2 diabetes mellitus and incident carotid atherosclerosis: a retrospective cohort study on composite indices

Li, L., Aini, W., & Jiang, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1904890

Microbial fermentation of medicine-food homology plants for type 2 diabetes mellitus intervention: From molecular structural remodeling to gut-host metabolic crosstalk

Ma, X., Zhu, P., Yan, K., Fan, L., Luo, A., & Li, J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109847

Repurposing metabolic drugs: Anti-diabetic and anti-obesity agents with potential in cancer therapy

Uti, D. E., Almohaimeed, H. M., Aggad, W. S., Egbung, J. E., Anthony, B. O., Ogar, R. O., & Alum, E. U. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100747

Coronary Plaque Burden, Distribution, and Perivascular Fat Characteristics in Patients with Diabetes Mellitus: A Coronary CT Angiography Study

Xu, X., Song, P., Wei, X., Li, H., Hu, J., & Tian, X. (2026) · Academic Radiology · doi:10.1016/j.acra.2026.09.022

Individual Cardiometabolic Risk Factors and Long-Term Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver DiseasePreprint

Shibata, N., Morita, Y., Ito, T., Kanzaki, Y., Watanabe, N., Yoshioka, N., Arao, Y., Miyazawa, H., Yasuda, S., Toyoda, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11164764/v1

Integrative Multi-Omics Reveals Distinct Molecular Signatures of Metabolic Syndrome from KORA FF4 Study

Bazireh, H., Efiong, E. E., Adam, J., Wang‐Sattler, R., Suhre, K., Adamski, J., Lintelmann, J., Schlesinger, S., Cecil, A., Witting, M. A., et al. (2026) · Metabolites · doi:10.3390/metabo16110821

Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes

Echeverria-Ortegon, E., Torres-Chavez, M. C., Tejeda, A. P., Caballero, P., Pastor-Cervantes, J. A., & Laviada‐Molina, H. (2026) · Clinical Cardiology · doi:10.1002/clc.70480

Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis

Jiang, W., & Du, H. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70329

Effect of Lipid Management on Coronary Heart Disease Risk in Persons With Type 2 Diabetes

Brandts, J., & Ray, K. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00019-7

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works

Distinct compositional alterations in plasma lipoproteins in type 2 diabetes: a cross-sectional study of healthy individuals and diabetics with and without cardiovascular comorbidities

Tsay, E., Kurmaeva, D., Nuriddinov, S., Tsoy, V., Abduxalimova, S., Bozorov, S. S., Khalimova, Z., Engelsen, S. B., Magkos, F., Akbarovna, D. D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03039-2

Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

Arungovind, G., Kamalanathan, A. S., & Venkataraman, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_20 · Cited by 1 · see citing works

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients

Peela, J. R., Latiwesh, O. B., Elshaari, F. A., Hussain, A., Tabrez, E. S., Viglianco, E., Edwards, A., Ali, F., & Rawal, A. K. (2018) · Cureus · doi:10.7759/cureus.3030 · Cited by 9 · see citing works